Azilsartan: Current Evidence and Perspectives in Management of Hypertension

Figure 2

Milestones of development of various ARB’s. Eprosartan was another ARB developed in 1992 by Glaxo Smithkline but not marketed in our country though approved by USFDA; losartan got USFDA approval only in 1995.